StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3013% above fair value
$7.56−4.46 (-37.10%)

Close on Nov 13, 2026Market cap $259.49MP/E –Yield 0.00%

NeuroPace price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

NeuroPace's price to sales ratio was 4.3× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 0.8× to 6.9×, with a median of 4.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.3×−1.3
2025Dec 31, 20255.7×+1.3
2024Dec 31, 20244.4×−0.1
2023Dec 29, 20234.5×+3.6
2022Dec 30, 20220.8×−4.6
2021Dec 31, 20215.5×–

More NeuroPace figures

See a number that looks wrong?